Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.380
+0.045 (3.39%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $3.41 million as of April 25, 2025. Its market cap has decreased by -49.62% in one year.
Market Cap
3.41M
Enterprise Value
1.17M
1-Year Change
-49.62%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $11.31B to $3.41M, a decrease of -99.97%. That is a compound annual growth rate of -84.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 3.41M | -6.42% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.74% |
| Dec 31, 2020 | 11.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.40B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |